Child Neurology News Digest Sep 27, 2026

Child Neurology News Digest | Week Ending 27 September 2026 Welcome to this week’s Child Neurology News Digest from Child-Neurology.org. In this edition, we cover six critical developments in paediatric neurology, including new clinical trial results, updated practice guidance, and emerging research in neuro-oncology and neuroimmunology. Key Topics in This Episode: Pyruvate Dehydrogenase Complex Deficiency: Encouraging long-term results from the Phase 3 Dichloroacetate (DCA) trial. Congenital CMV: New American Academy of Pediatrics (AAP) guidance on screening and long-term surveillance. NF1 & Plexiform Neurofibromas: A multidisciplinary expert consensus on practical management and imaging. Medulloblastoma: Identifying KDM2B as a new epigenetic vulnerability in Group 3 and 4 tumours. Paediatric MOGAD: Expert insights on when to safely reduce or stop maintenance immunotherapy. Brain Injury & Glioma Biology: How ischaemic stroke may alter the brain environment to promote tumour infiltration. Stay informed with the latest evidence and clinical relevance in the field. Visit us at: https://child-neurology.org for more updates, reviews, and professional learning resources. #ChildNeurology #MedicalNews #Paediatrics #NeurologyUpdate #CMV #NF1 #Medulloblastoma #MOGAD #ClinicalResearch #ChildNeurologyNews